Your browser doesn't support javascript.
loading
Sortilin-related receptor is a druggable therapeutic target in breast cancer.
Al-Akhrass, Hussein; Pietilä, Mika; Lilja, Johanna; Vesilahti, Ella-Maria; Anttila, Johanna M; Haikala, Heidi M; Munne, Pauliina M; Klefström, Juha; Peuhu, Emilia; Ivaska, Johanna.
Affiliation
  • Al-Akhrass H; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Pietilä M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Lilja J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Vesilahti EM; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Anttila JM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Haikala HM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Munne PM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Klefström J; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Peuhu E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Ivaska J; Institute of Biomedicine, Cancer Research Laboratory FICAN West, University of Turku, Finland.
Mol Oncol ; 16(1): 116-129, 2022 01.
Article in En | MEDLINE | ID: mdl-34564954

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Finland

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Finland